Press release
Rising Global Cancer Prevalence Fuels Anticancer Monoclonal Antibodies (MABS) Market Growth: A Key Driver Powering Anti-Cancer MAbS Market Growth In 2025
Anti-Cancer MAbS Market
What Is the Anti-Cancer MAbS Market Size and Projected Growth Rate?
The anti-cancer mAbs market size has grown rapidly in recent years. It will increase from $69.33 billion in 2024 to $76.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth is driven by the rising incidence of cancer, improved understanding of cancer biology, increased adoption of personalized medicine, increased research and development investment, and growing patient awareness and demand for cancer treatments.
The anti-cancer mAbs market is set to reach $109.88 billion in 2029, growing at a CAGR of 9.3%. Growth drivers are immunotherapy improvements, combined treatment strategies, advanced mAb generations, cancer response initiatives, and expanded patient programs. Trends include enhanced drug delivery, AI in development, pharma collaborations, biotech progress, and CAR-T therapies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9041
What Are the Major Segments in the Anti-Cancer MAbS Market?
The anti-cancer mabs market covered in this report is segmented -
1) By Type: Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types
2) By Application: Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications
3) By End User: Hospitals, Research Institutes, Other End Users
Subsegments:
1) By Murine Antibodies: Murine IgG, Murine IgM, Other Murine Isotypes
2) By Chimeric Antibodies: Chimeric IgG, Chimeric IgM, Other Chimeric Isotypes
3) By Humanized Antibodies: Humanized IgG, Humanized IgM, Other Humanized Isotypes
4) By Other Types: Fully Human Antibodies, Bispecific Antibodies, Conjugated Antibodies, Other Novel Formats
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9041&type=smp
What Are The Driving Anti-Cancer MAbS Market Evolution?
The rising global incidence of cancer is expected to drive the growth of the anticancer monoclonal antibodies (mAbs) market. Anticancer mAbs are engineered to target specific proteins on cancer cells, helping to destroy them. In January 2022, PubMed reported that approximately 1.9 million new cancer cases were expected globally, with 609,360 cancer-related deaths in the U.S. The growing cancer rates are expected to continue boosting the anticancer mAbs market.
Which Firms Dominate The Anti-Cancer MAbS Market Segments?
Major companies operating in the anti-cancer mabs market include Amgen Inc., Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Merck & Co. Inc., Spectrum Pharmaceuticals Inc., AstraZeneca plc., Pfizer Inc., Gilead Sciences Inc., Bayer HealthCare, ImmunoGen Inc., Genentech Inc., AbbVie Inc., Takeda Pharmaceuticals, Seattle Genetics, Regeneron Pharmaceuticals, Celgene, Ipsen, Daiichi Sankyo, Kite Pharma, ADC Therapeutics, MacroGenics Inc., BioXcel Therapeutics, Zymeworks Inc., Exelixis Inc., Blueprint Medicines, Erytech Pharma, Oncopeptides AB
What Are the Latest Developing Trends in the Anti-Cancer MAbS Market?
Product innovation is a major trend in the anticancer monoclonal antibodies (mAbs) market. Leading companies in this sector are introducing new and more effective treatments, such as mAb drugs, to strengthen their market position. For example, in May 2022, Roche Holding AG, a Switzerland-based pharmaceutical company, launched PHESGO, a unique monoclonal antibody combination treatment for HER2-positive early breast cancer. PHESGO combines pertuzumab and trastuzumab with the enzyme hyaluronidase, allowing for subcutaneous administration instead of intravenous infusion.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anti-cancer-mabs-global-market-report
Which Is The Largest Region In The Anti-Cancer MAbS Market?
The countries covered in the anti-cancer mAbs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anti-Cancer MAbS Market?
2. What is the CAGR expected in the Anti-Cancer MAbS Market?
3. What Are the Key Innovations Transforming the Anti-Cancer MAbS Industry?
4. Which Region Is Leading the Anti-Cancer MAbS Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Global Cancer Prevalence Fuels Anticancer Monoclonal Antibodies (MABS) Market Growth: A Key Driver Powering Anti-Cancer MAbS Market Growth In 2025 here
News-ID: 4058453 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
